Practical Licensing 13-16 November 2018


Is this course right for me?

The course is designed for people with some experience of licensing, e.g. they have run a few smaller deals themselves or have been involved indirectly in a larger licensing deal. Delegates will probably have been working in a tech transfer role for somewhere between 12 months and 3 years. 

Those with experience of research contracts, even without direct commercial licensing experience, will also find this beneficial – although the focus of the course will be on a stand-alone licensing deals, licensing issues will often need to be addressed as part of a research contract negotiation.

The course is viewed from the perspective of universities licensing their technology to industry (which may include to a spin-out company), but it’s equally valuable for those working in industry who are dealing on the other side of the fence as it will enable them to understand the unique pressures that a university is under when licensing its technology. 

It may also be useful to those working in funding bodies, particularly those that require or expect the universities to undertake some form of commercial exploitation of the work to better understand the complexities and difficulties of striking a licensing deal.

This is a natural follow on course to Fundamentals of Technology Transfer; indeed, many of the topics introduced there are developed further in this course.

Delegates are not expected to have any legal training, but a basic understanding of IP will be beneficial.


Why should I attend this course?

  • Licensing is a common route for knowledge exchange, but the complexities can make this a slow and painful process. 
  • Licensing early stage technology is often difficult. Universities in particular face unique challenges on the terms they can accept when licensing their IP that industry is not always aware of.
  • This course will give the delegates the tools they need to better structure their licence deals and give them the confidence to negotiate the key terms.
  • Licensing is not just relevant for the ‘big ticket’ tech transfer deals; licence terms are often included in research funding agreements, collaboration agreements, etc.


What will I learn from the course?

  • Learn how to formulate a licensing strategy (which will include a financial strategy)
  • Understand the key issues in a licence agreement and how the principles inter-relate
  • Gain confidence for negotiating the terms of a licence agreement
  • Understand and be able to assess the risks of ‘less than favourable’ terms.
  • Explore both successful and unsuccessful licensing case studies and identify what worked and what could have been improved.
  • Learn how to manage the licensing relationship post-signature.

The course also focuses on networking, providing a valuable platform to meet peers, discuss best practice, and interact with the course team and other contributors.


PLEASE NOTE: There may be a requirement for delegates to undertake some pre-course work/reading before the course begins.


What makes this course different to others available in the sector?

PraxisAuril is able to deliver this training from the unique perspective of KE practitioners. We see the world from the same angle as you do!

We draw on a wide pool of experience and expertise from within the profession and build them into the course content, ensuring we are always delivering up to date, sector leading training and development.

View provisional programme


20% discount on group bookings

Make a 20% saving on course fees by registering five or more delegates from your organisation for this event.

The course fee includes:

  • Attendance at all lectures and workshops
  • Training and reference materials (electronic or otherwise)
  • Registration event (including buffet dinner & drinks) on Tuesday 13 November 2018
  • Networking event (including buffet dinner & drinks) on Wednesday 14 November 2018
  • Morning and afternoon refreshments and lunch every day


View Venue, Accommodation & Further Information




14 ATTP Points

13th November - 16th November


Course Fee (Members £1,045) £ 1175.00

Meet the Speakers/Trainers

Mr. Paul Maclennan

Course Director
Partner / Solicitor, Anderson Law LLP
Paul Maclennan is a solicitor and a Partner at Anderson Law LLP, a niche firm of commercial/IP solicitors based in Oxfordshire. Paul advises on a wide variety of commercial agreements focussing on transactional work within the IT, life sciences and university sectors. His clients include leading UK universities and an international IT/telecoms company. Paul is listed in Chambers & Partners as a leading UK lawyer in the field of Intellectual Property and is a contributor to a number of Anderson Law’s publications on intellectual property and commercial law, most recently Technology Transfer (3rd Ed, Bloomsbury, 2010). Paul can be reached at

Mark Pearce

Partner, Mills & Reeve LLP
Mark Pearce studied physics at Oxford University before working for two years as a research scientist with British Maritime Technology Limited. He joined leading London intellectual property lawfirm Bristows in 1987. After re-qualifying as a lawyer specialising in intellectual property law, Mark remained at Bristows until 1998 when he joined Dickinson Dees, which in 2013 became Bond Dickinson LLP. Mark left Bond Dickinson in December 2016 to join Mills & Reeve LLP. He has a particular interest in technology transfer issues and advises a number of universities and spin-out businesses. He was involved in the spin-out of Orla Protein Technologies Limited from Newcastle University and of Durham Pipeline Technology Limited from Durham University amongst others. He continues to advise a number of technology businesses which originated in universities. He has also been involved in technology transfer issues in the health service and was a member of the external panel of NHS Innovations North which manages the North East NHS IP Hub.

Mrs. Carina Healy

Partner, CMS Cameron McKenna
Carina Healy is a Partner in CMS Cameron McKenna's Technology Non-Contentious team. Carina specialises in life sciences, having worked in this area for the past 18 years. She advises a wide range of clients including universities, speciality pharma companies, biotechs, and medical device companies, and investors in life sciences companies. Her clients include University College London and UCL Business plc, University of Glasgow, Dundee University, University of Aberdeen, NuCana BioMed, Consilient Health and Synpromics Limited. Carina is often approached to act for clients on strategically important life sciences transactions and on agreements with large pharmaceutical, diagnostics and medical device companies including product licensing and acquisitions, large scale clinical trials, and co-development agreements. Carina is qualified in both Scots and English law.

Andrew Tingey

Director of Healthcare Licensing, Imperial Innovations Ltd
Andrew Tingey joined Imperial Innovations in December 2014 as Director of Healthcare Licensing and heads the team that sources, develops and licenses new technologies in the healthcare sector from Imperial College London.

Previously, Andrew was Director of Licensing at Royal DSM NV, where he led the DSM corporate licensing team based near Maastricht, the Netherlands. Andrew had previously held successive positions as group portfolio licensing manager at Fusion IP plc and senior managerial and R&D roles at Reading Scientific Services Ltd, an independent scientific analysis, consultancy, product development and training company.

Andrew has held Certified Licensing Professional accreditation since 2012 and also holds a PhD in biochemistry from the University of Leicester, a BSc in biochemistry from the University of York and an MBA from The Open University in the United Kingdom.

Dr. David Phillips

Senior Commercialisation Manager, Queen Mary Innovation Ltd
David Phillips is a molecular geneticist and virologist by background and has worked managing, developing and licensing intellectual property for nearly 20 years. David has spent considerable time out-licensing from academic institutions, including the University of Oxford’s technology transfer office, and in licensing and managing and auditing the technology transfer process which follows a license deal. Large and medium sized pharmaceutical company experience (including GSK and Goldshield) on technologies both nascent and mature, sits alongside generics licensing and software experience. In his spare time David particularly enjoys winter sports, actively competing on Skeleton around Europe.
Join the waiting list